Published August 31, 2015 | Version v1
Journal article Open

Monitoring of the treatment effect of the secondary myopathy syndrome in patients with juvenile rheumatoid arthritis

Creators

  • 1. Vinnitsya national medical university N.I. Pirogov memorial

Description

Dudnyk V. M., Bereznyckyi O. V., Vyzhga Yu. V. Monitoring of the treatment effect of the secondary myopathy syndrome in patients with juvenile rheumatoid arthritis. Journal of Education, Health and Sport. 2015;5(8):443-447. ISSN 2391-8306. DOI 10.5281/zenodo.31323

http://dx.doi.org/10.5281/zenodo.31323

http://ojs.ukw.edu.pl/index.php/johs/article/view/2015%3B5%288%29%3A443-447

https://pbn.nauka.gov.pl/works/632554

Formerly Journal of Health Sciences. ISSN 1429-9623 / 2300-665X. Archives 2011–2014 http://journal.rsw.edu.pl/index.php/JHS/issue/archive

 

Deklaracja.

Specyfika i zawartość merytoryczna czasopisma nie ulega zmianie.

Zgodnie z informacją MNiSW z dnia 2 czerwca 2014 r., że w roku 2014 nie będzie przeprowadzana ocena czasopism naukowych; czasopismo o zmienionym tytule otrzymuje tyle samo punktów co na wykazie czasopism naukowych z dnia 31 grudnia 2014 r.

The journal has had 5 points in Ministry of Science and Higher Education of Poland parametric evaluation. Part B item 1089. (31.12.2014).

© The Author (s) 2015;

This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland and Radom University in Radom, Poland

Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium,

provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License

(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.

This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial

use, distribution and reproduction in any medium, provided the work is properly cited.

The authors declare that there is no conflict of interests regarding the publication of this paper.

Received: 26.08.2015. Revised 05.09.2015. Accepted: 24.09.2015.

 

Monitoring of the treatment effect of the secondary myopathy syndrome in patients with juvenile rheumatoid arthritis

 

V. M. Dudnyk, O. V. Bereznyckyi, Yu. V. Vyzhga

 

Vinnitsya national medical university N.I. Pirogov memorial

 

Abstaract

The syndrome of the secondary myopathy is one of the pathologies that is deeply spreaded in doctor’s practice and has a tendency to be increased being 30 – 60% of all chronicle pain syndromes in rheumatology practice. We provided examination of 43 patients with JRA to monitor effect of the treatment. The data presents that development of the secondary myopathy syndrome in patients with JRA is characterized with severe clinical currency of the disease, high inflammatory activity and significant influence on the quality of patient’s life so needed to be treated specific.

Key words: secondary myopathy, juvenile rheumatoid arthritis. 

Notes

Dudnyk V. M., Bereznyckyi O. V., Vyzhga Yu. V. Monitoring of the treatment effect of the secondary myopathy syndrome in patients with juvenile rheumatoid arthritis. Journal of Education, Health and Sport. 2015;5(8):443-447. ISSN 2391-8306. DOI 10.5281/zenodo.31323 http://dx.doi.org/10.5281/zenodo.31323 http://ojs.ukw.edu.pl/index.php/johs/article/view/2015%3B5%288%29%3A443-447 https://pbn.nauka.gov.pl/works/632554 Formerly Journal of Health Sciences. ISSN 1429-9623 / 2300-665X. Archives 2011–2014 http://journal.rsw.edu.pl/index.php/JHS/issue/archive

Files

2015_5_8_443-447_2988.pdf

Files (262.7 kB)

Name Size Download all
md5:4336953d5f76c6f0d390b1868f95d441
262.7 kB Preview Download

Additional details

References

  • 1. Consolaro A. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score / Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, Pederzoli S, Davì S, Martini A, Ravelli A; Paediatric Rheumatology International Trials Organization // Arthritis Rheumatology. – 2012. – Vol. 7. – P. 2366 – 2372.
  • 2. Ellis A. Justine. Possible Environmental Determinants of Juvenile Idiopathic Arthritis / Justine A. Ellis, Jane E. Munro, Anne-Louise Ponsonby // Rheumatology. – 2010. – Vol. 3. – P. 411 – 425.
  • 3. Huang JL. New advances in juvenile idiopathic arthritis / Huang JL. // Chang Gung Med J. – 2012. – Vol. 35. – P. 1 – 14.
  • 4. Klepper SE. Measures of pediatric function: Child Health Assessment Questionnaire (C-HAQ), Juvenile Arthritis Functional Assessment Scale (JAFAS), Pediatric Outcomes Data Collection Instrument (PODCI), and Activities Scale for Kids (ASK) / Klepper SE // Arthritis Care Research. – 2011. – Vol. 11. – P. 371 – 382.
  • 5. Susic GZ. Analysis of disease activity, functional disability and articular damage in patients with juvenile idiopathic arthritis: a prospective outcome study / Susic GZ, Stojanovic RM, Pejnovic NN, Damjanov NS, Soldatovic II, Jablanovic DB, Sefik Bukilica MN. // Clinical Expert Rheumatology. – 2011. – Vol. 2. – P. 337 – 341.
  • 6.Targonska-Stepniak Bozena Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis / Bożena Targońska-Stępniak, Maria Majdan // Clinical rheumatology. – 2010. – vol. 29. – P. 38 – 42.